9 completed, 6 recruiting, 4 not yet recruiting, 2 active not recruiting. 9 Not applicable, 8 Phase 4, 3 Phase 2, 1 Phase 3.
Follow Tor Biering-Sørensen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Electronic Letters to Improve Patient Activation in IHD: The NUDGE-IHD Trial LDL-C information letter, Lp(a) information letter - Ischemic Heart Disease, Coronary Artery Disease | Not applicable | Not yet recruiting | Tor Biering-Sørensen | 123000 | 2026-09-01 | 2026-09-08 |
| Effectiveness of An Influenza/COVID-19 Vaccine (mCombriax [mRNA-1083]) in Adults ≥ 65 Years mCombriax® (mRNA-1083), Efluelda® (TIV-HD) and Spikevax® (mRNA-1273) - COVID-19, Influenza | Phase 4 | Not yet recruiting | Tor Biering-Sørensen | 410000 | 2026-09-01 | 2026-08-27 |
| Recombinant Herpes Zoster Vaccine for Prevention of Cardiovascular Events and Dementia Recombinant Herpes Zoster Vaccine (Shingrix) - Cardiovascular Disease, Dementia | Phase 4 | Active not recruiting | Tor Biering-Sørensen | 168460 | 2026-04-28 | 2026-10-14 |
| Hemodynamic Effects of Ketone Esters in Patients With Sepsis Induced Cardiomyopathy Ketone ester, Placebo - Sepsis Induced Cardiomyopathy | Not applicable | Not yet recruiting | Tor Biering-Sørensen | 12 | 2026-03-10 | 2026-03-04 |
| Effectiveness of mRNA-1273 Variant-Containing Vaccine Formulation Against Severe Outcomes in Adults Aged 50-64 Years Without Risk Factors for Severe COVID-19 mRNA-1273 (Moderna COVID-19 vaccine) - COVID-19 | Phase 4 | Completed | Tor Biering-Sørensen | 41060 | 2025-12-11 | 2026-10-06 |
| A Danish Pragmatic Randomized Trial of Nutritional Supplements in Heart Failure Coenzyme Q10 100 Milligrams Oral Capsule, Selenium 100 Micrograms Oral Tablets - Heart Failure | Phase 3 | Recruiting | Tor Biering-Sørensen | 4044 | 2025-09-30 | 2025-10-03 |
| Pooled Analysis of Methodologically Harmonized Pragmatic Randomized Trials of High-Dose vs. Standard-Dose Influenza Vaccine Against Severe Clinical Outcomes High-Dose Influenza Vaccine, Standard-Dose Influenza Vaccine - Influenza | Phase 4 | Completed | Tor Biering-Sørensen | 466320 | 2025-05-31 | 2025-09-12 |
| Randomized Comparison of Morning Versus Bedtime Administration of Statins: A Cardiovascular Circadian Chronotherapy (C3) Trial Statin in the evening (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin), Statin in the morning (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin) - Cardiovascular Diseases (CVD), Drug Effect | Phase 4 | Not yet recruiting | Tor Biering-Sørensen | 42000 | 2025-02-28 | 2025-03-04 |
| Copenhagen Heart Failure With Preserved Ejection Fraction Heart Failure With Preserved Ejection Fraction (HFPEF) | Recruiting | Tor Biering-Sørensen | 5000 | 2025-02-28 | 2025-03-05 | |
| Vaccine Effectiveness of a Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing RSV Hospitalizations in Adults RSV prefusion F protein-based vaccine - RSV | Phase 4 | Active not recruiting | Tor Biering-Sørensen | 690000 | 2024-11-18 | 2026-05-29 |
| Nationwide Utilization of Danish Government Electronic Letter System for Confirming the Effectiveness of Behavioral Nudges in Increasing InFLUenza Vaccine Uptake Among Adults With Chronic Disease Behavioral Economic Principles - Influenza, Behavior and Behavior Mechanisms | Not applicable | Completed | Tor Biering-Sørensen | 308978 | 2024-10-01 | 2025-09-12 |
| Nationwide Utilization of Danish Government Electronic Letter System for Increasing Guideline-directed Medical Therapy in Chronic Kidney Disease Electronically delivered nudging letters to patients with CKD, Electronically delivered nudging letter to associated GPs of patients with CKD - Chronic Kidney Diseases, Behavior and Behavior Mechanisms | Not applicable | Completed | Tor Biering-Sørensen | 28388 | 2024-08-19 | 2025-09-29 |
| Danish Pragmatic Randomized Trial to Evaluate the Effect of HeartLogic-Guided Management on Heart Failure Outcomes HeartLogic - Heart Failure | Not applicable | Recruiting | Tor Biering-Sørensen | 1428 | 2024-05-31 | 2025-09-12 |
| Coronary Computed Tomography AngioGraphy Prior to Catheter Ablation in Patients With Atrial FIBrillation Analysis of coronary CT Angiography and CAC scoring at the time of catheter ablation - Atrial Fibrillation | Not applicable | Recruiting | Tor Biering-Sørensen | 852 | 2024-03-26 | 2024-06-26 |
| The COLchicine HEART Failure PRESERVED Trial (COLHEART-PRESERVED) Colchicine, Placebo - Heart Failure With Preserved Ejection Fraction | Phase 2 | Unknown | Tor Biering-Sørensen | 152 | 2024-01-18 | 2024-02-28 |
| Randomized Comparison of Morning Versus Bedtime Administration of Aspirin: A Cardiovascular Circadian Chronotherapy (C3) Trial Aspirin - Atherosclerosis, Cardiovascular Diseases | Phase 4 | Recruiting | Tor Biering-Sørensen | 32706 | 2024-01-15 | 2024-02-06 |
| Nationwide Utilization of Danish Government Electronic Letter System for Increasing InFLUenza Vaccine Uptake Among Adults With Chronic Disease Behavioral Economic Principles - Influenza, Behavior and Behavior Mechanisms | Not applicable | Completed | Tor Biering-Sørensen | 299881 | 2023-09-24 | 2024-10-10 |
| Nationwide Utilization of Danish Government Electronic Letter System for Confirming the Effectiveness of Behavioral Nudges in Increasing InFLUenza Vaccine Uptake Among Older Adults Behavioral Economic Principles - Influenza, Behavior and Behavior Mechanisms | Not applicable | Completed | Tor Biering-Sørensen | 881373 | 2023-09-14 | 2024-10-10 |
| A Pragmatic Randomized Trial to Evaluate the Effectiveness of High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in Older Adults High-Dose Quadrivalent Influenza Vaccine, Standard-Dose Quadrivalent Influenza Vaccine - Influenza | Phase 4 | Completed | Tor Biering-Sørensen | 332438 | 2022-09-22 | 2025-09-12 |
| Nationwide Utilization of Danish Government Electronic Letter System for Increasing InFLUenza Vaccine Uptake Behavioral Economic Principles - Influenza, Behavior and Behavior Mechanisms | Not applicable | Completed | Tor Biering-Sørensen | 964870 | 2022-09-16 | 2024-10-10 |
Showing 20 of 22. Sign in to see all of them.
Influenza, Human (8) · Behavior (5) · Cardiovascular Diseases (5) · Respiratory Tract Diseases (3) · Atherosclerosis (2) · COVID-19 (2) · Coronary Artery Disease (2) · Heart Diseases (2) · Heart Failure (2) · Myocardial Ischemia (2) · Pneumonia (2) · Renal Insufficiency, Chronic (2) · Atrial Fibrillation (1) · Dementia (1) · Herpes Zoster (1)
Influenza Vaccines (3) · 2019-nCoV Vaccine mRNA-1273 (2) · Apolipoproteins A (1) · Aspirin (1) · Atorvastatin (1) · Colchicine (1) · Hydroxymethylglutaryl-CoA Reductase Inhibitors (1) · Pravastatin (1) · Rosuvastatin Calcium (1) · Simvastatin (1) · dapagliflozin (1) · formic acid 4-(3-oxobutyl)phenyl ester (1)
Denmark (21) · Spain (2)
Camilla Ikast Ottosen, MD (1) · Manan Pareek, MD, PhD (1)
PMID 39550717, PMID 38460754, PMID 41968745, PMID 35449028, PMID 36649484, PMID 36801265, PMID 36871213, PMID 36889332, PMID 37211967, PMID 38117499, PMID 38286177, PMID 38320035, PMID 38498876, PMID 38586966, PMID 38770818, PMID 39215149, PMID 39215646, PMID 39303788, PMID 39392741, PMID 39606218, PMID 40174694, PMID 40481660, PMID 40738309, PMID 40749884, PMID 40844659, PMID 40884411, PMID 40884442, PMID 40884493, PMID 40888695, PMID 40888720, PMID 41115437, PMID 41147829, PMID 41177098, PMID 41212981, PMID 41213006, PMID 41238377, PMID 41525066, PMID 41985620, PMID 42666088, PMID 42666095, PMID 42702887
2025 (2)